UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Transmission of tauopathy strains is independent of their isoform composition

Nature communications, 2020-01, Vol.11 (1), p.7-7, Article 7

2020

Volltextzugriff (PDF)

Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau

Science (American Association for the Advancement of Science), 2020-11, Vol.370 (6519)

2020

Volltextzugriff (PDF)

ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration

Alzheimer's & dementia, 2021-05, Vol.17 (5), p.822-830

2021

Volltextzugriff (PDF)

Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review

JAMA neurology, 2019-01, Vol.76 (1), p.101

2019

Volltextzugriff (PDF)

Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Acta neuropathologica communications, 2019-03, Vol.7 (1), p.34-34, Article 34

2019

Volltextzugriff (PDF)

Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1572-1587

2020

Volltextzugriff (PDF)

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model

The Journal of biological chemistry, 2023-07, Vol.299 (7), p.104876-104876, Article 104876

2023

Volltextzugriff (PDF)

Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies

Journal of neuropathology and experimental neurology, 2018-03, Vol.77 (3), p.216-228

2018

Volltextzugriff (PDF)

Tau immunotherapy is associated with glial responses in FTLD-tau

Acta neuropathologica, 2021-08, Vol.142 (2), p.243-257

2021

Volltextzugriff (PDF)

ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration

Brain (London, England : 1878), 2020-07, Vol.143 (7), p.2295-2311

2020

Volltextzugriff (PDF)

In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics

Acta neuropathologica, 2021-02, Vol.141 (2), p.193-215

2021

Volltextzugriff (PDF)

GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils

The Journal of neuroscience, 2017-11, Vol.37 (47), p.11485-11494

2017

Volltextzugriff (PDF)

Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library

European journal of medicinal chemistry, 2020-03, Vol.189, p.112023-112023, Article 112023

2020

Volltextzugriff (PDF)

Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum

Acta neuropathologica, 2020-11, Vol.140 (5), p.675-693

2020

Volltextzugriff (PDF)

Regulation of Wnt Signaling Target Gene Expression by the Histone Methyltransferase DOT1L

ACS chemical biology, 2015-01, Vol.10 (1), p.109-114

2015

Volltextzugriff (PDF)

Astroglial tau pathology alone preferentially concentrates at sulcal depths in chronic traumatic encephalopathy neuropathologic change

Brain communications, 2020-01, Vol.2 (2), p.fcaa210-fcaa210

2020

Volltextzugriff (PDF)

Novel Carboxaldehyde Mediated Synthetic Pathway for 5′-Amino Adenosine Analogues

Nucleosides, nucleotides & nucleic acids, 2015, Vol.34 (5), p.348-360

2015

Volltextzugriff (PDF)

Synthesis of orthogonally reactive FK506 derivatives via olefin cross metathesis

Bioorganic & medicinal chemistry, 2009-08, Vol.17 (16), p.5763-5768

2009

Volltextzugriff (PDF)

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies: Human neuropathology/selective vulnerability

Alzheimer's & dementia, 2020-12, Vol.16 (S2)

2020

Volltextzugriff (PDF)

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology: Biomarkers (non‐neuroimaging) / Differential diagnosis

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL)

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL): Biomarkers (non‐neuroimaging) / Differential diagnosis

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

Detection of Alzheimer's disease

Acta neuropathologica communications, 2019-03, Vol.7 (1)

2019

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transmission of tauopathy strains is independent of their isoform composition

Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau

ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration

Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review

Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease

Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model

Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies

Tau immunotherapy is associated with glial responses in FTLD-tau

ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration

In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics

GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils

Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library

Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum

Regulation of Wnt Signaling Target Gene Expression by the Histone Methyltransferase DOT1L

Astroglial tau pathology alone preferentially concentrates at sulcal depths in chronic traumatic encephalopathy neuropathologic change

Novel Carboxaldehyde Mediated Synthetic Pathway for 5′-Amino Adenosine Analogues

Synthesis of orthogonally reactive FK506 derivatives via olefin cross metathesis

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies

Preferential degeneration of the locus coeruleus in tauopathies relative to TDP‐43 proteinopathies: Human neuropathology/selective vulnerability

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology: Biomarkers (non‐neuroimaging) / Differential diagnosis

Lower neocortical tau burden distinguishes Alzheimer’s pathology occurring with vs. without primary non‐Alzheimer’s pathology

ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL)

ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL): Biomarkers (non‐neuroimaging) / Differential diagnosis

Detection of Alzheimer's disease

Suchergebnisse filtern